利拉格卢提德调节释放,改善胰岛素抵抗性衰老心肌细胞中的线粒体功能
Fatemeh Hosseinpourshirazi1, Umur D Mendes2, Zeynep B Aksoy1
1Stem Cell Institute, Ankara University, Ankara, Turkey.
Cardiovascular toxicology
|January 28, 2026
概括
利拉格卢提德治疗增加了细胞内,并改善了老年胰岛素抵抗细胞中的线粒体功能. 这凸显了它在治疗与衰老和胰岛素抵抗相关的代谢疾病方面的潜力.
科学领域:
- 心血管生物学 心血管生物学
- 代谢性疾病研究研究
- 细胞衰老 细胞衰老
背景情况:
- 衰老和胰岛素抵抗是导致代谢疾病的关键因素,如2型糖尿病和心血管疾病.
- 葡萄糖类-1 (GLP-1) 受体激动剂,如利拉格卢提德,显示潜在的心脏保护作用.
- 利拉格卢提德对抗胰岛素衰老细胞的具体影响尚不清楚.
研究的目的:
- 调查利拉格卢提德对细胞内,氧化应激,线粒体功能和内质网膜 (ER) 应激的作用.
- 利用人类AC16细胞中胰岛素抵抗和衰老的新型模型.
- 阐明素激酶2在利拉格卢提德信号通路中的作用.
主要方法:
- 使用棕酸和D-银糖建立了抗胰岛素衰老细胞模型.
- 评估葡萄糖摄取量,β-Galactosidase染色和p-H2A.X水平,以确认衰老和胰岛素抵抗.
- 评估了细胞内,线粒体膜潜力,活性氧物种和蛋白质稳定标志物在利拉格卢提德治疗后,有或没有素激酶2抑制.
主要成果:
- 在模型中,慢性利拉格卢提德治疗显著增加了细胞内水平.
- 利拉格卢提德改善了线粒体膜潜力,并减少了反应性氧物种.
- 素激酶2抑制阻断了利拉格卢提德诱导的升和线粒体益处,表明其关键作用.
结论:
- 利拉格卢提德调节了老年胰岛素抵抗细胞中的细胞内和内细胞网膜-线粒体通信.
- 慢性利拉格卢提德的使用显示了与衰老和胰岛素抵抗相关的代谢性心肌病的治疗潜力.
- 氨酸激酶2是利拉格卢提德对细胞健康有益作用的关键调解剂.
相关概念视频
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
890
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
890
02:59Animal Mitochondrial Genetics
9.2K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
9.2K
02:19Export of Mitochondrial and Chloroplast Genes
4.2K
A eukaryotic cell can have up to three different types of genetic systems: nuclear, mitochondrial, and chloroplast. During evolution, organelles have exported many genes to the nucleus; this transfer is still ongoing in some plant species. Approximately 18% of the Arabidopsis thaliana nuclear genome is thought to be derived from the chloroplast’s cyanobacterial ancestor, and around 75% of the yeast genome derived from the mitochondria’s bacterial ancestor. This export has occurred...
4.2K
02:15Replicative Cell Senescence
4.4K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.4K
02:16Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes
15.9K
The present-day mitochondrial and chloroplast genomes have retained some of the characteristics of their ancestral prokaryotes and also have acquired new attributes during their evolution within eukaryotic cells. Like prokaryotic genomes, mitochondrial and chloroplast genomes neither bind with histone-like proteins nor show complex packaging into chromosome-like structures, as observed in eukaryotes. Unlike mitotic cell divisions observed in eukaryotic cells, mitochondria and chloroplasts...
15.9K
01:05Insulin Secretory Vesicles
6.8K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
6.8K